Comment on: "The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review"
Appl Health Econ Health Policy
.
2019 Apr;17(2):255-256.
doi: 10.1007/s40258-018-0441-3.
Authors
Carlos Vílchez-Román
1
2
,
Sol Sanguinetti
3
4
,
Edward Mezones-Holguín
5
6
Affiliations
1
CENTRUM Católica Graduate Business School (CCGBS), Jirón Daniel Alomía Robles 125, Lima 33, Peru. cvilchez@pucp.edu.pe.
2
Pontificia Universidad Católica del Perú (PUCP), Av. Universitaria 1801, Lima 32, Peru. cvilchez@pucp.edu.pe.
3
School of Communications, Universidad de Lima (ULima), Javier Prado Este Cuadra 46 S/N, Lima 33, Peru.
4
Environment and Technology Institute (ETI), Jirón Bach BH2, Lima 33, Peru.
5
Centro de Excelencia en Estudios Económicos y Sociales en Salud, Universidad San Ignacio de Loyola (USIL), Avenida La Fontana 550, Lima, Peru.
6
Epi-gnosis Solutions, Santiago Távara 174, Piura, Peru.
PMID:
30370432
DOI:
10.1007/s40258-018-0441-3
No abstract available
Publication types
Letter
Comment
MeSH terms
Drug Costs*
Drugs, Generic*
Humans
Substances
Drugs, Generic